NCCN Guidelines for Patients® | Diffuse Large B-cell Lymphoma

64 NCCN Guidelines for Patients ® : Diffuse Large B-cell Lymphoma, 2017 Index Index 2 nd opinion 52 biopsy 10, 38–40, 42 blood stem cell transplant 33–34, 38–39, 42–43, 44–45 blood tests 16–17, 42 bone marrow exam 19 cancer stage 20 , 21, 38 chemotherapy 27–29, 38–40, 42, 44 clinical trial 35, 38–40, 42–43, 44–45 complementary and alternative medicine (CAM) 34 complete blood count (CBC) 16 comprehensive metabolic panel 16 computed tomography (CT) 19, 42 diagnosis 10–13 double-hit lymphoma 13 fertility 22 immunohistochemistry (IHC) 12 immunomodulators 26 immunotherapy 25–26 involved-site radiation therapy (ISRT) 31, 44 lumbar puncture 20 lymphatic system 8 lymphocyte 8 lymphoma 8–10 medical history 15, 42 NCCN Member Institutions 63 NCCN panel members 62 observation 42 pathology report 13 physical exam 16, 42 positron emission tomography/computed tomography (PET/CT) 18, 38–40, 42, 44 radiation therapy 31–32, 38–40, 42–43, 44–45 shared decision-making 47 steroids 30 supportive care 29, 41, 44–45 targeted therapy 30

RkJQdWJsaXNoZXIy MTE3MTE1